Inventor

Jaedeok Yoo

Inventor
Princeton, NJ, US

Overview

19→
Patents
2001–2019
Patent span
Performing operations
Primary field (CPC B)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

B33Yprimary
B33YAdditive manufacturing, i.e. manufacturing of three-dimensional [3d] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3d printing, stereolithography or selective laser sintering27%
B29CShaping or joining of plastics17%
A61KPreparations for medical, dental or toiletry purposes13%
B29LIndexing scheme associated with subclass b29c, relating to particular articles11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%
Y10TTechnical subjects covered by former us classification10%
A61FFilters implantable into blood vessels6%
A61LMethods or apparatus for sterilising materials or objects in general3%
A61BDiagnosis1%
C04BLime, magnesia1%
PatentTitleYear
10,449,712Three-dimensional printing system and equipment assembly201910,118,335Three-dimensional printing system and equipment assembly20189,908,293'Three-dimensional printing system and equipment assembly'20189,610,735'Three-dimensional printing system and equipment assembly'20179,517,591'Three-dimensional printing system and equipment assembly'20169,517,592'Three-dimensional printing system and equipment assembly'20169,463,160'Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same'20169,114,072'Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same'20158,888,480'Three-dimensional printing system and equipment assembly'20148,465,777'Diffusion-controlled dosage form and method of fabrication including three dimensional printing'20138,088,415'Diffusion-controlled dosage form and method of fabrication including three dimensional printing'20127,875,290'Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form'20117,857,860'Bone void filler and method of manufacture'20107,276,252'Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form'20077,122,057'Method and apparatus for engineered regenerative biostructures such as hydroxyapatite substrates for bone healing applications'20066,547,994'Rapid prototyping and manufacturing process'20036,514,518'Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof'20036,471,992'Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same'20026,280,771'Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2016Patents assigned to MASSACHUSETTS INST TECHNOLOGY (8)· patent assignee history
2001–2003Patents assigned to THERICS INC (4)· patent assignee history
2001–2003Based in Philadelphia, PA, US· patent location history
2006–2016Based in West Orange, NJ, US· patent location history
2010–2012Based in East Windsor, NJ, US· patent location history
2012–2016Patents assigned to YOO JAEDEOK (4)· patent assignee history
2013–2019Based in Princeton, NJ, US· patent location history
2014–2018Patents assigned to APRECIA PHARMACEUTICALS CO (5)· patent assignee history
2018–2019Patents assigned to Aprecia Pharmaceuticals LLC (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MASSACHUSETTS INST TECHNOLOGY82001–2016
APRECIA PHARMACEUTICALS CO52014–2018
THERICS INC42001–2003
YOO JAEDEOKself42012–2016
Aprecia Pharmaceuticals LLC32018–2019
Locations
LocationPatentsSpan
Princeton, New Jersey, US92013–2019
West Orange, New Jersey, US42006–2016
Philadelphia, Pennsylvania, US42001–2003
East Windsor, New Jersey, US22010–2012